HubSpot
| CURRENT PRICE | PROBABILITY-WEIGHTED FAIR VALUE | FAIR VALUE RANGE |
|---|---|---|
| ~$203 | ~$230 | $165 – $290 |
| Aug 6, 2026, ~−19% on the print — confirm on live feed | House view: Cheap, but growth decelerating | Q2 beat; FY revenue guide cut |
New coverage · August 2026: HubSpot reported Q2 2026 after the close on August 5, 2026. Figures below are verified against the company's SEC Form 8-K (Item 2.02) earnings release[1]; analyst actions and estimate beats/misses are from Benzinga Pro[2].
House View: Cheap enough to matter, but the growth story is fading (August 2026). This was the mirror image of AppLovin: HubSpot beat the quarter and cut the outlook. Q2 revenue of $911.7M grew 20% as-reported (17% constant currency) and beat the ~$898M consensus; non-GAAP EPS of $3.26 beat $3.02; non-GAAP operating margin expanded to 20.3% and the company generated $168M free cash flow and authorized a fresh $1.0B buyback. But the guide is what the market traded: management lowered FY26 revenue guidance to $3.678–3.686B (below the ~$3.707B Street) and set Q3 revenue of $924–925M (~14% growth, below the ~$942M estimate), even while raising the FY non-GAAP EPS guide to $13.23–13.31 on better margins. Growth decelerating from 20% toward the mid-teens — amid a deliberate AI/pricing transition (agents, seat-and-usage pricing) — was enough to send the stock down ~19% to ~$203 and trigger downgrades (Oppenheimer to Perform, Piper Sandler to Neutral) with targets cut to a ~$200–250 band (Barclays $240, BTIG $250, Cantor $200). The offset is valuation: at ~$203 the stock trades around ~15x FY26 non-GAAP EPS and low-single-digit EV/sales — genuinely cheap for a profitable, cash-generative platform buying back stock. Our base (~$235) gives modest credit for that valuation and the buyback while respecting the decelerating top line; the bull (~$290) needs the AI-pricing transition to re-accelerate growth, and the bear (~$165) is a world where CRM/marketing software keeps de-rating and AI disrupts seat-based models.
CURRENT SNAPSHOT
| Metric | Value | Notes / Source |
|---|---|---|
| Stock price | ~$203 | Aug 6, 2026, ~−19% on the print (prev close ~$250) [3] |
| Market cap | ~$10.2B | ~50.6M shares × ~$203 [1] |
| Q2 2026 revenue | $911.7M (+20% YoY) | Beat ~$898M est; +17% cc [2] |
| Q2 2026 EPS | $3.26 non-GAAP / $0.86 GAAP | Non-GAAP beat $3.02 est [2] |
| Non-GAAP op margin / FCF | 20.3% / $168M | Op income +44% YoY [1] |
| Customers / ARPU | 306,446 (+14%) / $11,800 | Calculated billings $929.7M (+14%) [1] |
| Cash / buyback | $1.4B cash; new $1.0B buyback | $531.9M repurchased in Q2 [1] |
| Q3 2026 guide | Rev $924–925M; EPS $3.25–3.27 | Below Street ($942M / $3.45) [1] |
| FY26 guide | Rev $3.678–3.686B (lowered); EPS $13.23–13.31 (raised) | Sales below $3.707B est; EPS above $13.10 [1] |
| Street PTs (post-print) | ~$200 – $250 | Barclays $240, BTIG $250, Cantor $200; downgrades [2] |
BULL / BASE / BEAR SCENARIOS
HubSpot is profitable and cash-generative, so scenarios flex the FY27 revenue growth rate and the P/E the market assigns as growth normalizes. Weights: Bull 25% / Base 50% / Bear 25%.
| Scenario (weight) | Driver | Approx. multiple | Fair value |
|---|---|---|---|
| Bull (25%) | AI agents and new pricing re-accelerate growth back toward 20%; multiple re-rates on the cheap base | ~20x FY27E EPS | ~$290 |
| Base (50%) | Growth settles in the mid-teens, margins keep expanding, buyback supports EPS; modest re-rate off a depressed multiple | ~16x FY27E EPS | ~$235 |
| Bear (25%) | Growth keeps decelerating, AI disrupts seat-based CRM economics, multiple stays compressed | ~11x FY27E EPS | ~$165 |
| Probability-weighted | — | — | ~$230 |
Probability-weighted fair value ~$230, ~13% above the ~$203 tape. The low absolute multiple, 20%+ non-GAAP margins, strong FCF and a fresh $1B buyback create a valuation floor; the constraint on the upside is the decelerating top line and the open question of how AI reshapes seat-based software pricing.
Key Risks & Watch Points
- Growth deceleration: The core risk is the top line — a slide from 20% toward low-teens would keep the multiple compressed regardless of margins.
- AI / pricing transition: Moving from seat-based to agent/usage pricing is a bet; if it confuses customers or cannibalizes seats, near-term revenue suffers.
- Competition: Salesforce, Microsoft, and AI-native CRM entrants pressure HubSpot's upmarket push.
- Macro / SMB exposure: HubSpot skews to scaling/SMB customers, which are more macro-sensitive than enterprise.
- FX: ~3pts of the reported growth is currency; a stronger dollar would pressure as-reported numbers.
What Would Change Our View
- Upside: Evidence the AI-pricing transition is re-accelerating net-new bookings, stabilizing billings growth, and continued margin expansion.
- Downside: Another guide-down, customer-add or ARPU deceleration, or signs AI is compressing seat counts across the CRM category.
Sources
[1] SEC Form 8-K (Item 2.02), HubSpot Q2 2026 earnings release, filed Aug 5, 2026 — sec.gov/Archives/…/hubs-ex99_1.htm
[2] Benzinga Pro — HubSpot news feed & analyst actions (Q2 EPS $3.26 beat $3.02, rev $911.7M beat $898M est; Q3 guide $924–925M vs $942M est and FY sales lowered vs $3.707B est; post-print: Oppenheimer downgrade to Perform, Piper Sandler downgrade to Neutral $220, Barclays $240, BTIG $250, Cantor Neutral $200) — pro.benzinga.com
[3] https://finance.yahoo.com/quote/HUBS/
Disclaimer
This output is for informational and research-assistance purposes only. It does not constitute investment, legal, tax, accounting, or other professional advice, and it is not a recommendation to buy, sell, or hold any security or instrument or to pursue any strategy. Information may be incomplete, estimated, delayed, or inaccurate. Past performance does not guarantee future results. Verify material facts independently and consult qualified advisors before making decisions.